Copper binding to the N-terminal metal-binding sites or the CPC motif is not essential for copper-induced trafficking of the human Wilson Protein (ATP7B) by Cater, Michael et al.
Biochem. J. (2007) 401, 143–153 (Printed in Great Britain) doi:10.1042/BJ20061055 143
Copper binding to the N-terminal metal-binding sites or the CPC motif
is not essential for copper-induced trafficking of the human Wilson
protein (ATP7B)
Michael A. CATER, Sharon LA FONTAINE and Julian F. B. MERCER1
Centre for Cellular and Molecular Biology, School of Biological and Chemical Sciences, Deakin University, 221 Burwood Highway, Burwood, VIC 3125, Australia
The Wilson protein (ATP7B) is a copper-translocating P-type
ATPase that mediates the excretion of excess copper from hep-
atocytes into bile. Excess copper causes the protein to traffic from
the TGN (trans-Golgi network) to subapical vesicles. Using site-
directed mutagenesis, mutations known or predicted to abrogate
catalytic activity (copper translocation) were introduced into
ATP7B and the effect of these mutations on the intracellular traf-
ficking of the protein was investigated. Mutation of the critical
aspartic acid residue in the phosphorylation domain (DKTGTIT)
blocked copper-induced redistribution of ATP7B from the TGN,
whereas mutation of the phosphatase domain [TGE (Thr-Gly-
Glu)] trapped ATP7B at cytosolic vesicular compartments. Our
findings demonstrate that ATP7B trafficking is regulated with its
copper-translocation cycle, with cytosolic vesicular localization
associated with the acyl-phosphate intermediate. In addition, mut-
ation of the six N-terminal metal-binding sites and/or the trans-
membrane CPC (Cys-Pro-Cys) motif did not suppress the consti-
tutive vesicular localization of the ATP7B phosphatase domain
mutant. These results suggested that copper co-ordination by these
sites is not essential for trafficking. Importantly, copper-chelation
studies with these mutants clearly demonstrated a requirement
for copper in ATP7B trafficking, suggesting the presence of an
additional copper-binding site(s) within the protein. The results
presented in this report significantly advance our understanding of
the regulatory mechanism that links copper-translocation activity
with copper-induced intracellular trafficking of ATP7B, which is
central to hepatic and hence systemic copper homoeostasis.
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INTRODUCTION
The P-type ATPase ATP7B plays a pivotal role in mammalian
copper homoeostasis and defects in this protein cause the copper-
toxicity disorder Wilson disease [1]. P-type ATPases are an exten-
sive family of transmembrane proteins that mediate the transloc-
ation of various cations, including Mg2+, Ca2+, Na+, K+, Zn2+,
Ag+ and Cu+, across cellular membranes and often against con-
centration gradients [2]. Mammals have two copper-translocating
P-type ATPases: ATP7B and its paralogue ATP7A. Both proteins
contain the characteristic features of P-type ATPases which in-
clude an ATP-binding site (GDGIND), a phosphorylation domain
[DKTGT(I,L)T], a phosphatase domain [TGE (Thr-Gly-Glu)] and
eight transmembrane regions (Figure 1) [1–3]. In addition, heavy-
metal-transporting P-type ATPases, such as ATP7A and ATP7B,
form a subfamily termed CPX-type ATPases [4]. Members of the
subfamily are characterized by a variable number of heavy MBSs
(metal-binding sites) (GMXCXXC) in the N-terminal region and a
conserved Cys-Pro-Xaa motif (Xaa=cysteine, histidine or serine)
in the proposed cation transduction channel (Figure 1) [4]. Both
ATP7A and ATP7B have six N-terminal GMXCXXC motifs,
which have been shown to preferentially bind copper with a stoi-
chiometry of one copper atom per binding motif [5]. The CPC
(Cys-Pro-Cys) motif situated in the sixth transmembrane domain
has also been shown to bind copper, which may facilitate trans-
location of the cation through the membrane [6,7].
The enzymatic properties of both copper-ATPases conform to
the classical P-type ATPase model [2,8]. Phosphorylation of the
aspartic acid residue in the phosphorylation domain is required
for copper translocation and is dependent on the presence of
cation (copper) and ATP [9,10]. The transiently phosphorylated
intermediate (acyl-phosphate) is sensitive to basic pH, ADP and
treatment with hydroxylamine and the enzymes are inhibited
by the structural homologue of Pi, orthovanadate [9,10]. Acyl-
phosphorylation drives protein conformational changes leading
to the translocation of the bound cations across the lipid bilayer
[2]. The reaction cycle is completed with hydrolysis of the
acyl-phosphate (dephosphorylation) by an intrinsic phosphatase
activity (via TGE motif) and the pump is returned back to its
original conformation to allow further cation binding and transloc-
ation [2,8,11].
ATP7A and ATP7B are likely to have evolved from a single
ancestral copper-ATPase to perform specific functions in different
cell types. ATP7B is expressed predominantly in liver hepatocytes
[12] but also in regions of the brain [13], breast [14] and pla-
centa [15], while ATP7A is expressed in most extra-hepatic tissues
[16]. Studies on the subcellular localization of the copper-ATPases
have shown that both proteins reside at the final compartment of
the Golgi apparatus, the TGN (trans-Golgi network) [17–19]. At
this location, copper is incorporated into various cuproenzymes
such as lysyl oxidase in fibroblasts (mediated by ATP7A) [20] or
ceruloplasmin in hepatocytes (mediated by ATP7B) [21]. In hep-
atocytes, an increase in copper levels stimulates trafficking of
ATP7B to pericanalicular vesicles and ATP7B recycles back to
the TGN when copper concentrations are decreased [22,23]. The
target vesicles for ATP7B have not been characterized and are
possibly novel compartments that sequester excess copper and
undergo a mechanism similar to lysosomal exocytosis to expel
Abbreviations used: BCS, bathocuproinedisulfonic acid; CHO-K1, Chinese-hamster ovary K1; CPC motif, Cys-Pro-Cys motif; MBS, metal-binding site;
TGE, Thr-Gly-Glu; TGN, trans-Golgi network; wt, wild-type.
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Figure 1 Schematic representation of ATP7B
Transmembrane domains are numbered 1 to 8. Filled rectangles represent the six N-terminal
MBSs (GMXCXXC). The amino acids mutated in the present study and their positions in ATP7B
are shown. The conserved domains are as follows: phosphorylation domain, D1027KTGTIT;
phosphatase domain, TGE858−860; ATP-binding domain, G1266DGVND; CPC motif, CPC983−985.
Protein orientation is from cytosolic side facing to luminal side, the direction in which ATP7B
translocates copper across the membrane.
their luminal contents into bile [23–25]. ATP7A displays similar
copper-induced trafficking to ATP7B, but relocates from the TGN
to the basolateral membrane in polarized cells [22], where it can
efflux copper directly from the cell [26]. In non-polarized cell
types, ATP7A traffics to the plasma membrane [19], while ATP7B
traffics to a dispersed population of cytosolic vesicles [17,18].
The predominant subcellular localization of each copper-ATPase
depends on copper levels, although recycling between the
compartments is likely to be constitutive in the presence of either
high or low concentrations of copper [26].
We have previously shown that the copper-induced trafficking
of ATP7A is regulated with its catalytic cycle [11]. Formation
of the acyl-phosphorylated intermediate (catalytic activation) is
required for ATP7A redistribution to the plasma membrane, while
hydrolysis of the acyl-phosphate (dephosphorylation) is essential
for the retrieval of trafficked ATP7A molecules back to the TGN
[11]. In the present study, we show that the trafficking of ATP7B
is also coupled with its catalytic activity, with the vesicular
localization associated with its acyl-phosphate intermediate.
Surprisingly, copper co-ordination by either the six N-terminal
MBSs or the CPC motif is not essential for ATP7B trafficking
even though the trafficking process is dependent on copper.
This observation suggests the presence of an additional copper-
binding site(s) in the molecule. The results presented in this
report represent significant progress towards understanding the
mechanism by which copper regulates the subcellular localization
of its own transporter.
EXPERIMENTAL
Cells, reagents and antibodies
CHO-K1 (Chinese-hamster ovary K1) cells were cultured as
monolayers in Eagle’s Basal Medium (Trace BioSciences, Nobel
Park, VIC, Australia) supplemented with 0.2 mM proline, 10%
(v/v) foetal calf serum, 2 mM L-glutamine, 1.2 mM NaHCO3
and 20 mM Hepes (Commonwealth Serum Laboratories,
Broadmedows, VIC, Australia). Transfection of CHO-K1 cells
with plasmid DNA was performed using LipofectamineTM (Life
Technologies, Mount Waverley, VIC, Australia) and the manufac-
turer’s recommendations. Transfected cells were selected using
500 µg/ml G418 (Life Technologies) for 14 days. The Saccharo-
myces cerevisiae mutant strain, ccc2 (MATα, his3-200, trp-1-
101, ura3-52, leu2, ade5, ccc2::LEU2) [27], was cultured on
YPD solid medium containing 2% (w/v) trypticase peptone,
1% (w/v) yeast extract, 2% (w/v) glucose and 2% (w/v) agar.
This strain was transformed with plasmid DNA using a lithium
acetate method as previously described [28] and transformants
were selected on DOB-Ura medium composed of 0.66% (w/v)
yeast nitrogen base without amino acids, 2% glucose and 0.08%
(w/v) CSM (complete supplement mixture minus uracil). The
sheep polyclonal anti-ATP7B antibody (NC36) was raised against
amino acids 1–199 (N-terminal), 1309–1315 and 1376–1465 (C-
terminal) of human ATP7B as previously described [29]. All re-
agents used in the present study were purchased from Sigma
(Castle Hill, NSW, Australia) unless otherwise stated.
Generation of ATP7B key domain mutants
The Asp1027 residue in the phosphorylation domain was changed to
glutamate (D-E) by PCR-based mutagenesis of the ATP7B cDNA
as previously described [25]. PCR-based mutagenesis was also
used to change the Thr858, Gly859 and Glu860 residues in the phos-
phatase domain to alanine residues (TGE-AAA). In this case, the
oligonucleotides 5′-CAATACCATGGCTGATGAGTCCCTCAT-
CGCGGCCGCTGCCA-3′ (hWND#20) and 5′-TCTGTTCC-
AAGTTCCTCTT-3′ (hWND#19) were used to amplify nt 2544–
3259 of ATP7B. The oligonucleotide hWND no. 20 intro-
duced the desired codon changes, with the codons encoding the
alanine residues chosen to form a NotI restriction endonuclease
site. The PCR product was digested with HinfI and PinAI to
produce a 193 bp fragment (nt 2561–2753), which together with
an StuI/HinfI fragment isolated from pCMB278 (nt 2516–2753 of
ATP7B) was then ligated into PinAI/StuI-digested pCMB278. The
resultant plasmid was designated pCMB515. The ATP7B mutant
containing both the phosphorylation- and phosphatase-domain
changes (D-E + TGE-AAA) was generated by isolating the TGE-
AAA mutation from the pCMB515 plasmid using StuI/PinAI and
using this fragment to replace the corresponding wt (wild-type)
region in the D-E cDNA in pCMB514. The resultant plasmid was
designated pCMB516.
The ATP7B construct with the cysteine residues of the six
N-terminal MBSs mutated to serine residues (MBS1-6c/s) was
created as previously described [29]. To generate ATP7B with
the cysteine residues in the CPC983−985 motif mutated to serine
residues (CPC-SPS), the oligonucleotide 5′-CGGTTTGCTTTC-
CAGACGTCCATCACGGTGCTGTGCATTGCCTCACCCTC-
GTCCCTGGGGCTG-3′ (hWND#22) introduced the codon
changes when used in combination with 5′-GCTGACATCGCTA-
GAAAT-3′ (hWND#14) to amplify nt 2905–3499 of ATP7B. The
PCR product was digested with AatII and AocI to produce a
234 bp fragment (nt 2924–3159), which together with an AocI/
SalI fragment isolated from pCMB411 (nt 3160–4395 of
ATP7B) was then ligated into AatII/SalI-digested pCMB411. The
resulting plasmid was designated pCMB517. To create the final
expression construct, the entire CPC-SPS cDNA was isolated
from pCMB517 using XbaI/SalI and cloned into the Nhel/SalI
sites of pCMB77, generating pCMB518.
The following strategy was employed to create two ATP7B
double mutants, one containing the six N-terminal MBS mutations
and the phosphatase domain mutation (MBS1-6c/s + TGE-
AAA) and another in which the CPC motif and the phosphatase
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Table 1 Plasmids generated and used in the present study
Plasmid Characteristics Reference
pWSK29 Bacterial propagation vector [45]
pCMB77 Mammalian expression vector [19]
pVT-103U Yeast expression vector [30]
pCMB278 wtATP7B in pCMB77 [29]
pCMB514 D-E in pCMB77 [25]
pCMB515 TGE-AAA in pCMB77 Present study
pCMB516 D-E + TGE-AAA in pCMB77 Present study
pCMB517 CPC-SPS in pCMB411 Present study
pCMB518 CPC-SPS in pCMB77 Present study
pCMB519 CPC-SPS + TGE-AAA in pCMB77 Present study
pCMB398 MBS1-6c/s in pCMB77 [29]
pCMB520 MBS1-6c/s + TGE-AAA in pCMB77 Present study
pCMB521 MBS1-6c/s + CPC-SPS in pCMB77 Present study
pCMB522 MBS1-6c/s + CPC-SPS + TGE-AAA in pCMB77 Present study
pCMB554 wtATP7B in pVT-103U [29]
pCMB555 MBS1-2c/s in pVT-103U [29]
pCMB594 D-E in pVT-103U Present study
pCMB595 TGE-AAA in pVT-103U Present study
pCMB596 D-E + TGE-AAA in pVT-103U Present study
pCMB557 MBS1-6c/s in pVT-103U [29]
pCMB597 MBS1-6c/s + TGE-AAA in pVT-103U Present study
pCMB598 CPC-SPS in pVT-103U Present study
pCMB599 CPC-SPS + TGE-AAA in pVT-103U Present study
pCMB600 MBS1-6c/s + CPC-SPS in pVT-103U Present study
pCMB601 MBS1-6c/s + CPC-SPS + TGE–AAA in pVT-103U Present study
domain are mutated (CPC-SPS + TGE-AAA). The TGE-AAA
mutation (nt 2754–4395) was isolated from pCMB515 using
PinAI/SalI. This fragment was used to replace the corresponding
wt region in pCMB398 (resulting plasmid designated pCMB520)
and in pCMB515 (resulting plasmid designated pCMB519) res-
pectively. The ATP7B construct with the six N-terminal MBSs,
the CPC motif and the phosphatase domain mutated (MBS1-
6c/s + CPC-SPS + TGE-AAA) was engineered by isolating the
CPC-SPS and TGE-AAA mutations together from pCMB519 (nt
2153–4395) using StuI and SalI. This fragment was then cloned
into the StuI/SalI sites of the MBS1-6c/s cDNA in pCMB398,
replacing the corresponding wt region (resulting plasmid design-
ated pCMB522). The ATP7B construct with the six N-terminal
MBSs and the CPC motif mutated (MBS1-6c/s + CPC-SPS) was
generated by using StuI/PinAI to drop out the region in pCMB522
containing the TGE-AAA mutation and by replacing this fragment
with an StuI/PinAI fragment isolated from wtATP7B (from
pCMB278). The resultant plasmid was designated pCMB521. The
PCR-derived inserts and ligation sites in all constructs generated
were sequenced to confirm integrity. The plasmid constructs
generated and used in the present study are outlined in Table 1.
The ATP7B mutant constructs described above were incorpor-
ated into the yeast expression vector pVT-103U. This vector con-
tains the ADH1 (alcohol dehydrogenase 1) gene promoter, the 2µ
origin of replication for propagation in yeast, the URA3 marker
for plasmid selection in yeast, and the ori and intergenic region
of the phage f1 (f1 ori). In addition, pVT-103U also contains an
origin of replication and the β-lactamase gene for propagation and
selection (ampicillin resistance) in Escherichia coli [30]. ATP7B
cDNA constructs can be unstable in high copy number vectors.
Although pVT-103U is only an intermediate copy number vector
[30], ATP7B constructs generated using this vector were still pro-
pagated in the Able®-K E. coli strain (Stratagene, La Jolla, CA,
U.S.A.) to reduce the copy number 10-fold to ensure stable
propagation of ATP7B.
The ATP7B constructs were cloned into pVT-103U using the
following strategy. Nucleotides 494–4395 were removed from
wtATP7B in pVT-103U (pCMB554) or from MBS 1 + 2c/s
in pVT-103U (pCMB555) (previously described in [29]) using
BseAI and XhoI. These fragments were replaced with the
corresponding region from each ATP7B mutant cDNA, which
was isolated from their respective expression plasmids (shown in
Table 1) using BseAI and SalI. Constructs with MBS 1–2 mutated
were inserted into pCMB555. Digestion profiles, exploiting endo-
nuclease sites introduced during the generation of each mutant,
were used to verify that the mutant cDNAs replaced the wtATP7B
segment of pCMB554. Final plasmid constructs were designated
as shown in Table 1.
Protein preparation and Western-blot analysis
Yeast protein extracts were prepared using a trichloroacetic acid
method as described in Clontech’s Yeast Protocols Handbook
(PT3024-1). Whole cell protein extracts (30 µg) were fraction-
ated by SDS/PAGE (7.5% polyacrylamide). Following electro-
phoretic separation, proteins were transferred to nitrocellulose
(Amersham, Rydalmere, NSW, Australia) using a Trans-Blot SD
semi-dry electrophoretic transfer apparatus (Bio-Rad, Regents
Park, NSW, Australia) and immunoblot analysis was carried out
using the Lumi-Light chemiluminescence blotting kit (Roche,
Castle Hill, NSW, Australia) according to the manufacturer’s pro-
tocol. ATP7B was detected using the ammonium sulfate-precip-
itated NC36 antibody (diluted 1:1000) [29], followed by horse-
radish peroxidase-conjugated donkey anti-sheep IgG (Chemicon,
Boronia, VIC, Australia) (1:4000). Exposed HyperfilmTM
(Amersham) was fixed and developed using a Fuji medical film
processor (Fuji Photo Film).
Indirect immunofluorescence microscopy
Transfected CHO-K1 cells were seeded on to 13 mm glass cover-
slips in a 24-well tray and cultured for 16–72 h to approx. 50–
70% confluence. The growth medium was replaced with basal
medium (0.5–1 µM Cu), 200 µM CuCl2-supplemented medium
or a medium containing the copper chelators BCS (bathocuproine-
disulfonic acid; 200 µM) and D-penicillamine (200 µM) as indi-
cated in the results. Following treatment, cells were fixed using
4% (w/v) paraformaldehyde in PBS for 10 min and then per-
meabilized with 0.1% (v/v) Triton X-100 in PBS for 10 min. Cells
were blocked in 1% (w/v) BSA and 1% (w/v) gelatin in PBS at
4 ◦C overnight. For the detection of ATP7B, coverslips were in-
cubated with ammonium sulfate-precipitated NC36, diluted
1:10000 in blocking solution for 1 h. Following four PBS washes
(15 min each) coverslips were incubated (room temperature for
1 h) with the secondary antibody, donkey anti-sheep IgG Alexa
Fluor® 488 (1:4000; Chemicon) and again washed with PBS as
above. Coverslips were mounted on glass slides using 2.6% (w/v)
Dabco (Sigma) in 90% (v/v) glycerol. Immunolabelled cells were
analysed using a ×60 oil objective with an Olympus Provis AX70
microscope.
Complementation of S. cerevisiae ccc2
The S. cerevisiae ccc2 yeast strains that expressed wt and mutant
ATP7B proteins were each inoculated into 5 ml of DOB-Ura and
grown at 30 ◦C overnight to saturation. Serial 10-fold dilutions in
sterile distilled water were made in a 96-well plate starting from
10−1. For each dilution, 5 µl was applied in triplicate on to iron-
limited DOB-Ura agar plates containing 50 mM Mes and 250 µM
ferrozine and on to normal DOB-Ura plates to verify cell viability
and then incubated at 30 ◦C for 3 days. Images were taken using
a Canon digital IXUS V camera.
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Figure 2 Effect of mutating the phosphorylation and phosphatase domains on the trafficking of ATP7B
CHO-K1 cells transfected with wt or mutant ATP7B constructs [amino acid substitution(s) indicated on the left] were cultured in basal medium (0.5–1 µM Cu) or a medium supplemented with
200 µM CuCl2 (+Copper). Detection of ATP7B was performed by immunofluorescence analysis using ammonium sulfate-precipitated NC36 (diluted 1:10 000) and donkey anti-sheep IgG Alexa
Fluor® 488 (diluted 1:4000) (Chemicon). Photographs were taken using a ×60 oil objective with an Olympus Provis AX70 microscope.
RESULTS
Effect of mutations in the phosphorylation and phosphatase
domains on the subcellular localization and trafficking of ATP7B
Under basal copper conditions, the localization of ATP7B
to the TGN has been well established [17,18,25]. Despite
previous attempts [18,31], the cytosolic vesicular compartments
to which ATP7B traffics in elevated copper concentrations remain
undefined. In the present study, the effect of various mutations
within ATP7B on the ability of the protein to traffic from the
perinuclear region to cytosolic vesicles was assessed.
The invariant aspartate (Asp1027) in the phosphorylation domain
of ATP7B (DKTGTIT) has been shown to be essential for catalytic
activity [29]. To determine if this aspartate is also required for
the copper-induced trafficking of the protein, it was mutated
to glutamate (D-E) and the ability of the mutant protein to
traffic was studied in CHO-K1 cells (Figure 2). In cells cultured
under basal copper conditions (0.5–1 µM Cu), the D-E protein
was detected in the perinuclear region (Figure 2C), similar to
wtATP7B under the same conditions (Figure 2A). However, in
cells exposed to 200 µM copper for 2 h, the D-E protein remained
perinuclear (Figure 2D), while most of the wtATP7B molecules
redistributed to cytosolic vesicles (Figure 2B). Increasing copper
concentration to 400 µM and extending the exposure time to 4 h
had no observable effect on the localization of the D-E protein
(results not shown). These results demonstrate that Asp1027 is
required for the trafficking of ATP7B and support the hypothesis
that the copper-induced trafficking process is dependent on acyl-
phosphate formation [11].
Mutation of the phosphatase domain (TGE) in several P-type
ATPases, including both H+- and Ca2+-ATPase, has been shown
to prevent cation translocation and resulted in the accumulation
of the acyl-phosphorylated intermediate [32,33]. Mutation of the
TGE858−860 sequence in ATP7B to alanine residues (TGE-AAA)
caused constitutive vesicular localization of the protein (Fig-
ure 2E), resembling the distribution of wtATP7B in elevated levels
of copper (Figure 2B). There was no distinguishable difference in
the vesicular staining of the TGE-AAA protein when cells were
cultured in either basal medium or in a medium supplemented
with 200 µM CuCl2 (Figures 2E and 2F). This observation sug-
gested that even in basal copper concentrations acyl-phosphate
formation occurs, and in the absence of the intrinsic phosphatase
activity, most of the ATP7B molecules remain phosphorylated
and consequently are trapped at vesicular compartments.
To investigate whether the trafficking and vesicular localization
of the TGE-AAA protein was dependent on the presence of the
invariant aspartate (Asp1027), an ATP7B double mutant containing
the D-E and TGE-AAA mutations was generated. The D-E +
TGE-AAA protein localized abnormally in a hazy punctate pat-
tern throughout the cytosol when expressed in CHO-K1 cells (Fig-
ure 2G). This phenotype was observed in all transfected cells in the
absence and in the presence of 200 µM CuCl2 (Figure 2H). In
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Figure 3 Effect of temperature reduction on the subcellular localization and stability of ATP7B mutants
(A) Immunofluorescence analysis of CHO-K1 cells expressing wt or mutant ATP7B constructs [amino acid substitution(s) indicated on the left] cultured at 30◦C. Cells were cultured at 30◦C
for 3 days and then were incubated for 8 h (at 30◦C) with basal medium or a medium supplemented with 200 µM CuCl2 (+Copper) before being analysed by immunofluorescence microscopy.
Detection of ATP7B was performed as described in Figure 2. (B) Western-blot analysis comparing the amount of wtATP7B and D-E + TGE-AAA expression in CHO-K1 cells. Cells were cultured
for 3 days at either 37 or 30◦C before total cellular protein (∼ 50 µg) was subjected to SDS/PAGE (7.5 % polyacrylamide) and transferred to nitrocellulose. The membrane was incubated with
ammonium sulfate-precipitated NC36 (diluted 1:1000), followed by horseradish peroxidase-conjugated donkey anti-sheep IgG (diluted 1:4000) and analysed by chemiluminescence. The positions
of the molecular mass markers (Bio-Rad) are indicated on the left in kDa. The nitrocellulose was then stripped using Re-Blot Plus-Mild (Chemicon) and reblotted with mouse anti-β-actin monoclonal
antibody (diluted 1:5000) and horseradish peroxidase-conjugated sheep anti-mouse IgG (diluted 1:4000).
addition, there were clearly fewer cells in which the D-E + TGE-
AAA protein was detected in comparison with all other transfected
cell lines and the cells that expressed the mutant protein displayed
weak immunofluorescence staining (results not shown).
The D-E+ TGE-AAA mutant protein is temperature-sensitive
Temperature-sensitive proteins that contain tsf (temperature-sen-
sitive folding) mutations, which destabilize an intermediate in the
folding pathway, often can fold correctly and maintain normal
function when biosynthesized at a lower temperature [34]. To
determine if the aberrant localization of the D-E + TGE-AAA
protein was due to temperature-sensitive misfolding, CHO-K1
cells that express this mutant protein were incubated at 30 ◦C
for 3 days before being evaluated by immunofluorescence micro-
scopy (Figure 3A) and Western-blot analysis (Figure 3B). The
decrease in temperature resulted in the perinuclear staining of the
D-E + TGE-AAA protein [Figure 3A (e)], which was clearly dis-
tinct from the hazy punctate pattern observed at 37 ◦C [Figure 3A
(d)]. Elevated copper (200 µM) had no effect on the perinuclear
localization of D-E + TGE-AAA [Figure 3A (f)], whereas under
the same conditions most of the wtATP7B molecules trafficked to
cytosolic vesicles [Figure 3A (c)]. The reduction in temperature
also resulted in an increase in the number of cells in which
the D-E + TGE-AAA protein was detected (results not shown),
consistent with an increase in the stability of the D-E + TGE-AAA
protein at 30 ◦C. Western-blot analysis confirmed that culturing
the cells for 3 days at 30 ◦C increased the amount of intact, stable
D-E + TGE-AAA protein, while having no obvious effect on the
amount of wtATP7B (Figure 3B). Allowing the D-E + TGE-AAA
protein to assemble at a permissive temperature (30 ◦C) not only
corrected the subcellular localization of the protein [Figure 3A
(e)], but also revealed that the D-E substitution suppressed the
effect of the TGE-AAA mutation as the double mutant was
incapable of trafficking from the perinuclear region [Figure 3A
(f)]. To demonstrate that the vesicular localization of the TGE-
AAA protein did not arise from a similar temperature (sensitive)
effect, the effect of protein biosynthesis and assembly at 30 ◦C on
the subcellular localization of TGE-AAA was assessed [Figure 3A
(h and i)]. In cells cultured at 30 ◦C in either basal medium or a
medium supplemented with 200 µM copper, the TGE-AAA pro-
tein retained its cytosolic vesicular localization. Therefore the
vesicular localization of TGE-AAA is unlikely to have arisen
from protein misfolding.
Copper binding to the GMXCXXC and CPC motifs is not essential for
ATP7B trafficking
Mutation of the cysteine residues in all six N-terminal copper-
binding sites (GMXCXXC) to serine residues inhibited the
trafficking of ATP7B [29]. This observation was consistent with
copper binding to these sites being required for catalytic activation
(formation of the acyl-phosphate) leading to trafficking (Fig-
ures 4C and 4D). However, the failure of this and other ATP7B
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Figure 4 Effect of mutating copper-binding sites on the trafficking of ATP7B
CHO-K1 cells transfected with wt or mutant ATP7B constructs [amino acid substitution(s) indicated on the left] were cultured in basal medium (0.5–1 µM Cu) or a medium supplemented with
200 µM CuCl2 (+Copper). Detection of ATP7B was performed as described in Figure 2.
variants to traffic [17,31] could be due to either (i) the mutation
preventing formation of the acyl-phosphorylated intermediate or
(ii) slowing of the rate of catalysis to such an extent that the rate of
anterograde trafficking is less than the rate of retrieval back to the
TGN. In the latter case, ATP7B would not accumulate at the cyto-
solic vesicles. To distinguish between these two possibilities, the
six N-terminal copper-binding site mutations were combined with
the phosphatase domain mutation (MBS1-6c/s + TGE-AAA).
The mutant protein localized to vesicular compartments in both
basal medium (Figure 4E) and medium supplemented with
200 µM copper (Figure 4F), with a pattern of labelling indistingu-
ishable from that of the TGE-AAA protein (Figures 2E and
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2F). These results suggested that mutation of the six N-terminal
copper-binding sites alone perturbs, but does not completely
abrogate the trafficking of ATP7B.
If copper binding to ATP7B is responsible for initiating catalytic
activation and trafficking, then mutation of the copper-binding
site(s) involved would be expected to abolish these activities.
The CPC motif in the copper-ATPases (ATP7A and ATP7B) is
43 amino acids upstream of the phosphorylation domain
[DKTGT(I,L)T] (Figure 1) and is critical for the function of both
copper-ATPases [6,17,35,36]. It has been proposed that the CPC
motif may facilitate the translocation of copper through the
transmembrane region [7]. It is conceivable that binding of copper
to the CPC motif leads directly to acyl-phosphate formation. Mut-
ation of both cysteine residues in the CPC motif to serine residues
(CPC-SPS) prevented trafficking of ATP7B in CHO-K1 cells (Fig-
ures 4G and 4H). The CPC-SPS protein localized to the perinu-
clear region under both basal and elevated copper conditions
(Figures 4G and 4H), consistent with previous observations [6].
Surprisingly, when the TGE-AAA mutation was introduced into
the CPC-SPS protein, the double mutant localized to vesicles
in the absence and presence of added CuCl2 (Figures 4I and 4J).
This observation suggested that mutation of the CPC motif retards
rather than completely blocks the trafficking process, as observed
with the six N-terminal MBS mutations.
Possibly copper binding to either the N-terminal MBSs or the
CPC would be sufficient for acyl-phosphate formation and hence
trafficking. To investigate this hypothesis, a mutant protein in
which the six N-terminal MBSs, the CPC motif and the phosphat-
ase domain were mutated (MBS1-6c/s + CPC-SPS + TGE-AAA)
was expressed in CHO-K1 cells. This mutant protein localized to
vesicular compartments in both basal and 200 µM CuCl2-supple-
mented medium (Figures 4M and 4N). When the six N-terminal
MBSs and the CPC motif were mutated but the phosphatase
domain was left unchanged (MBS1-6c/s + CPC-SPS), the protein
localized to the perinuclear region (Figures 4K and 4L). This result
indicated that the combination of the MBS1-6c/s and the CPC-
SPS mutations was not responsible for the constitutive vesicular
localization of the MBS1-6c/s + CPC-SPS + TGE-AAA protein.
To demonstrate that the vesicular localization of this protein was
not due to folding irregularities caused by the multiple mutations,
CHO-K1 cells that expressed this mutant protein were incubated
at 30 ◦C for 3 days before being evaluated by immunofluorescence
microscopy [Figure 3A (k and l)]. Reducing the temperature had
no effect on the subcellular localization of the MBS1-6c/s + CPC-
SPS + TGE-AAA protein [Figure 3A (k and l)]. These results
suggested that while the six N-terminal MBSs and the CPC motif
are required for the efficient trafficking of ATP7B, surprisingly
they are not essential for trafficking to occur and, when mutated
together with the phosphatase domain (TGE-AAA), lead to accu-
mulation of ATP7B at vesicular compartments.
Copper chelation restores TGN localization of TGE-AAA mutants
If ATP7B is required to bind copper to initiate catalytic activation
and trafficking, then depleting intracellular copper should prevent,
or slow, the redistribution of the TGE-AAA mutants. To test
this hypothesis, cell lines that expressed the TGE-AAA mutants
were cultured in a medium containing the copper chelators BCS
(200 µM) and D-penicillamine (200 µM). With the exception of
the D-E + TGE-AAA protein (Figure 5F), all TGE-AAA mutants
localized to the perinuclear region when cells were incubated for
3 days with the copper chelators (Figure 5). Three days of incub-
ation were necessary to shift the steady-state localization of the
TGE-AAA mutants from cytosolic vesicles to the perinuclear
region (Figure 5); after only one or two days the proteins were still
observed in vesicles (results not shown). The D-E + TGE-AAA
protein retained the hazy punctate pattern under copper-depleted
conditions (Figure 5F). The overall number and appearance of the
cells was unchanged by the copper chelation treatment, suggest-
ing that the cells were still viable. Taken together, these results
demonstrate that copper availability was necessary for the consti-
tutive vesicular localization of the TGE-AAA mutants. Since the
two known copper-binding regions were mutated in the MBS1-
6c/s + CPC-SPS + TGE-AAA protein, these results raise the
possibility of an additional unrecognized copper-binding site(s)
in ATP7B.
The role of the key domains in the copper-translocation
activity of ATP7B
Any mutation that blocks a step in the catalytic cycle of ATP7B
will inhibit the translocation of copper by the protein. Thus mut-
ation of the phosphorylation (D-E) or the phosphatase domain
(TGE-AAA), both of which are required for ATP7B to complete
the copper-translocation cycle, should result in a non-functional
protein. The aspartate residue in the phosphorylation domain of
ATP7B is essential for catalytic activation [37]; however, the
importance of the phosphatase domain has not been evaluated.
The ATP7B key domain mutants were expressed in S. cerevisiae
ccc2 and evaluated for their copper-transport ability by assess-
ing the growth of the transformed yeast on iron-limited medium
(Figure 6A, –Fe). The ccc2 strain that expressed wtATP7B (or
wtATP7A) grew uniformly on iron-limited agar plates, while the
ccc2 strains that expressed the mutant proteins did not grow on
the same medium (Figure 6A, –Fe). The viability of the yeast
strains was confirmed on iron-sufficient medium (Figure 6A,
DOB-Ura). The failure of the ATP7B mutant proteins to comple-
ment the copper-transport defect of ccc2 was not due to low
expression levels, which were equivalent to or greater than
wtATP7B (Figure 6B).
DISCUSSION
In cells exposed to high concentrations of copper, both ATP7A and
ATP7B shift their steady-state localization from the TGN to either
the plasma membrane (ATP7A) or to cytosolic vesicles (ATP7B)
[17,19,23–25]. The copper-induced trafficking of ATP7A pre-
viously was shown to be regulated with the catalytic cycle of the
ATPase [11]. Consistent with this report, we show here that acyl-
phosphorylation was required for the trafficking of ATP7B and
dephosphorylation via the phosphatase domain was essential for
TGN retrieval of trafficked protein.
The combination of the D-E and TGE-AAA mutations led to
instability of the protein at 37 ◦C. Temperature-sensitive mutations
have been identified in ATP7B and include the patient muta-
tions H1069Q and M769V and several C- and N-terminal trunc-
ations [6,29,38,39]. Analysis at reduced temperatures previously
was used to determine the functional effect of the H1069Q and
M769V mutations [6,39]. In the present study, the subcellular
localization of D-E + TGE-AAA was corrected at the permissive
temperature (30 ◦C) and we demonstrated that the constitutive
vesicular accumulation of the TGE-AAA protein required the
aspartate residue (Asp1027), consistent with the requirement for
acyl-phosphorylation for trafficking of ATP7B to occur.
Copper binding by the copper-ATPases is believed to be res-
ponsible for initiating catalytic activation and regulating their
subcellular distribution [29,37,40]. The six N-terminal MBSs
(GMXCXXC) and the CPC motif are currently the only recog-
nized copper-binding motifs in both copper-ATPases. The
c© 2007 Biochemical Society
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Figure 5 Effect of copper chelation on the subcellular localization of the TGE-AAA mutants
CHO-K1 cells expressing the indicated wt or TGE-AAA mutant ATP7B proteins were cultured in basal medium or a medium containing the copper chelators BCS (200 µM) and D-penicillamine
(200 µM). Detection of ATP7B was performed as described in Figure 2.
TGE-AAA (phosphatase) mutation provided a valuable tool to de-
termine whether the N-terminal GMXCXXC sites or the CPC are
essential for trafficking, because it results in trafficked molecules
accumulating at cytosolic vesicles. Although the MBS1-6c/s and
CPC-SPS mutant proteins predominantly had perinuclear local-
ization in basal and elevated copper, when each was combined
with the TGE-AAA mutation to produce double mutants or
together to produce a triple mutant, the resultant proteins were
found at cytosolic vesicular compartments. These results show
that mutation of the N-terminal MBSs (MBS1-6c/s) and/or the
CPC motif (CPC-SPS) did not suppress the effect of the TGE-
AAA mutation, suggesting that copper co-ordination by these sites
is not essential for the formation of the acyl-phosphate interme-
diate required for trafficking. Nevertheless, copper was required
for the vesicular localization of the TGE-AAA mutants since
copper chelation confined the proteins to the perinuclear region
(Figure 5). These observations suggest that copper may bind to
another region of ATP7B leading to acyl-phosphate formation and
trafficking. Alternatively, the trafficking of these mutants may be
stimulated by another copper-binding protein(s) (such as a copper-
dependent kinase) that might interact with ATP7B to provide a
signal for acyl-phosphorylation to occur. Although the presence
of copper was previously shown to be critical for acyl-phosphate
formation [9], our results demonstrate that acyl-phosphorylation
and trafficking can occur in the absence of N-terminal or CPC
copper binding, albeit this process seems less efficient. This result
was unexpected, as most models of ATP7B (and ATP7A) function
envisage that copper is delivered to the N-terminal MBSs and is
c© 2007 Biochemical Society
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Figure 6 The ability of the ATP7B key domain mutants to complement S. cerevisiae ccc2
(A) S. cerevisiae ccc2 transformed with wt or mutant ATP7B constructs [amino acid substitution(s) indicated on the left] were analysed for their ability to grow on iron-depleted medium (–Fe).
Each yeast strain was inoculated in 5 ml of DOB-Ura and grown at 30◦C overnight to reach saturation. Serial 10-fold dilutions in sterile distilled water were made starting from 1:10 and 5 µl of each
dilution was applied on to the appropriate medium. Yeast strain viability was demonstrated by growth on iron-sufficient plates (DOB-Ura). (B) The ccc2 strains used in the copper-transport assay
described above were analysed for ATP7B expression by Western-blot analysis. Total cellular protein (30 µg) was fractionated by SDS/PAGE (7.5 % polyacrylamide) and transferred to nitrocellulose.
Protein was immunolabelled with ammonium sulfate-precipitated NC36 (diluted 1:1000), followed by horseradish peroxidase-conjugated donkey anti-sheep IgG (diluted 1:4000) and analysed by
chemiluminescence.
then transferred to the CPC residues. This latter step is thought to
be critical for initiating copper-dependent acyl-phosphorylation
[4,6,7]. However, the results obtained in the present study clearly
suggest an additional mechanism, namely that there is another
copper-binding site(s) to induce acyl-phosphate formation in
addition to the N-terminal MBS and the CPC motif. Several
methionine and cysteine residues located within transmembrane
regions are candidates for additional copper-binding sites, in
particular the highly conserved Met1393 in transmembrane domain
7, since mutation of this residue is responsible for the Wilson
disease phenotype in the toxic milk mouse [41] and is important
for copper translocation and acyl-phosphate formation in ATP7A
[10]. However, there is currently no direct evidence that any of
these residues co-ordinate copper.
Further studies are required to distinguish if the anterograde
movement of the copper-ATPases is directly linked to formation
of the acyl-phosphorylated intermediate or whether further down-
stream protein modifications are required. Possibly, a specific
conformation associated with the acyl-phosphate intermediate
exposes a trafficking signal or occludes a TGN retention sequence
(not mutually exclusive). Vanderwerf et al. [42] have reported a
correlation between kinase-dependent phosphorylation (distinct
from acyl-phosphorylation) of ATP7B and its trafficking to
cytosolic vesicles. These authors demonstrated that there are at
least two different sites in ATP7B that are phosphorylated by
unknown kinases and that elevated copper concentrations result
in hyper-phosphorylation of ATP7B coinciding with vesicular
redistribution [42]. Previously, we discovered that a putative
c© 2007 Biochemical Society
152 M. A. Cater, S. La Fontaine and J. F. B. Mercer
targeting motif exists within the sixth metal-binding domain of
ATP7B, which directs the protein to vesicular compartments [43].
Possibly the exposure or modification (e.g. kinase-dependent
phosphorylation) of this region subsequent to acyl-phosphoryl-
ation directs both copper-ATPases into the trafficking pathway and
the difference in this region between both proteins is responsible
for their respective post-Golgi destinations.
Previously, we used complementation of S. cerevisiae ccc2
to show that mutation of the six N-terminal MBSs inhibits the
copper-translocation ability of both ATP7A and ATP7B [29,43].
Using a different assay based on copper translocation into isolated
vesicles, Voskoboinik et al. [44] demonstrated that mutation of all
MBSs in ATP7A reduced, but did not abolish, copper-transloc-
ation activity. This observation is consistent with the constitutive
vesicular localization of the ATP7B MBS1-6c/s + TGE-AAA
protein, which suggested that the MBS1-6c/s protein possessed
reduced activity and this activity was detected by the introduction
of the TGE-AAA mutation that trapped the acyl-phosphate inter-
mediate at cytosolic vesicles. Thus we propose that the predomin-
ant perinuclear localization of the MBS1-6c/s and CPC-SPS
mutant proteins resulted from a reduction in the rate of cata-
lytic activation rather than complete abolition of activity. By slow-
ing down acyl-phosphate formation, the rate of anterograde traf-
ficking becomes less than the rate of perinuclear retrieval of
trafficked protein and therefore the mutant proteins display a
steady-state perinuclear localization.
Intracellular trafficking represents a switch in function for the
copper-ATPases from a role in copper delivery to cuproenzymes
at the TGN, to a protective role involving the transport of excess
copper into vesicles (ATP7B) and across the plasma membrane
(ATP7A) for excretion from the cell. The shift in the steady-
state localization of the copper-ATPases from the TGN can be
explained by an increase in the number of molecules that are cata-
lytically activated (acyl-phosphorylated). By coupling trafficking
with catalytic activity, this provides both autoregulation and an ap-
propriate distribution of the copper-ATPase between the TGN and
post-Golgi compartments following copper uptake [11]. When
intracellular copper is raised to a certain level, the number of cata-
lytically activated molecules is sufficient to maintain a steady-
state post-Golgi subcellular localization. Trafficking allows the
removal of excess copper, which results in the shift in the distri-
bution of the copper-ATPases back to the TGN.
The findings presented in this report substantiate the fact that
the intracellular trafficking of ATP7B requires acyl-phosphate
formation. Importantly, formation of the acyl-phosphate inter-
mediate was not entirely dependent on copper co-ordination by
the six N-terminal MBSs or the CPC motif, although these sites
clearly enhance the efficiency of the trafficking process. We
have demonstrated that copper was indeed still essential for the
trafficking of ATP7B and thus our data allude to the presence of
an as yet unrecognized copper-binding site(s) that contributes to
the efficiency of ATP7B trafficking.
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